Amneal pharmaceuticals inc AMRX.US 總覽分析
)AMRX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，若以價值投資為目標，已經有長期投資部位可能需陸續減碼
AMRX 近期報酬表現
2.56%
Amneal pharmaceuticals inc
4.57%
同產業平均
3.26%
S&P500
與 AMRX 同產業的標的表現
- TEVA Teva pharmaceutical industries limited價值 3 分趨勢 3 分波段 5 分籌碼 4 分股利 1 分查看更多
AMRX 公司資訊
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson's disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.